Global Neuropathic Pain Therapeutics Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Market Analysis by Type
  • 1.3.1 Global Neuropathic Pain Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.3.2 Anticonvulsants
  • 1.3.3 Antidepressants
  • 1.3.4 NSAIDs
  • 1.3.5 Opioids
  • 1.3.6 Steroids
  • 1.3.7 Others
• 1.4 Market by Application
  • 1.4.1 Global Neuropathic Pain Therapeutics Market Share by Application: 2020 VS 2026
  • 1.4.2 Diabetic Neuropathy
  • 1.4.3 Chemotherapy-Induced Neuropathy Pain
  • 1.4.4 Postherpetic Neuralgia
  • 1.4.5 Spinal Cord Injury
  • 1.4.6 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Neuropathic Pain Therapeutics Market Perspective (2015-2026)
• 2.2 Neuropathic Pain Therapeutics Growth Trends by Regions
  • 2.2.1 Neuropathic Pain Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Neuropathic Pain Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Neuropathic Pain Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Neuropathic Pain Therapeutics Industry Dynamic
  • 2.3.1 Neuropathic Pain Therapeutics Market Trends
  • 2.3.2 Neuropathic Pain Therapeutics Market Drivers
  • 2.3.3 Neuropathic Pain Therapeutics Market Challenges
  • 2.3.4 Neuropathic Pain Therapeutics Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Neuropathic Pain Therapeutics Players by Market Size
  • 3.1.1 Global Top Neuropathic Pain Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Neuropathic Pain Therapeutics Revenue Market Share by Players (2015-2020)
• 3.2 Global Neuropathic Pain Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Neuropathic Pain Therapeutics Revenue
• 3.4 Global Neuropathic Pain Therapeutics Market Concentration Ratio
  • 3.4.1 Global Neuropathic Pain Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Neuropathic Pain Therapeutics Revenue in 2019
• 3.5 Key Players Neuropathic Pain Therapeutics Area Served
• 3.6 Key Players Neuropathic Pain Therapeutics Product Solution and Service
• 3.7 Date of Enter into Neuropathic Pain Therapeutics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Neuropathic Pain Therapeutics Breakdown Data by Type

• 4.1 Global Neuropathic Pain Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Neuropathic Pain Therapeutics Forecasted Market Size by Type (2021-2026)

5 Neuropathic Pain Therapeutics Breakdown Data by Application

• 5.1 Global Neuropathic Pain Therapeutics Historic Market Size by Application (2015-2020)
• 5.2 Global Neuropathic Pain Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Neuropathic Pain Therapeutics Market Size (2015-2026)
• 6.2 North America Neuropathic Pain Therapeutics Market Size by Type (2015-2020)
• 6.3 North America Neuropathic Pain Therapeutics Market Size by Application (2015-2020)
• 6.4 North America Neuropathic Pain Therapeutics Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Neuropathic Pain Therapeutics Market Size (2015-2026)
• 7.2 Europe Neuropathic Pain Therapeutics Market Size by Type (2015-2020)
• 7.3 Europe Neuropathic Pain Therapeutics Market Size by Application (2015-2020)
• 7.4 Europe Neuropathic Pain Therapeutics Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Neuropathic Pain Therapeutics Market Size (2015-2026)
• 8.2 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Type (2015-2020)
• 8.3 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Application (2015-2020)
• 8.4 Asia-Pacific Neuropathic Pain Therapeutics Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia

9 Latin America

• 9.1 Latin America Neuropathic Pain Therapeutics Market Size (2015-2026)
• 9.2 Latin America Neuropathic Pain Therapeutics Market Size by Type (2015-2020)
• 9.3 Latin America Neuropathic Pain Therapeutics Market Size by Application (2015-2020)
• 9.4 Latin America Neuropathic Pain Therapeutics Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Neuropathic Pain Therapeutics Market Size (2015-2026)
• 10.2 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Type (2015-2020)
• 10.3 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Application (2015-2020)
• 10.4 Middle East & Africa Neuropathic Pain Therapeutics Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE

11Key Players Profiles

• 11.1 Pfizer
  • 11.1.1 Pfizer Company Details
  • 11.1.2 Pfizer Business Overview
  • 11.1.3 Pfizer Neuropathic Pain Therapeutics Introduction
  • 11.1.4 Pfizer Revenue in Neuropathic Pain Therapeutics Business (2015-2020))
  • 11.1.5 Pfizer Recent Development
• 11.2 Novartis AG
  • 11.2.1 Novartis AG Company Details
  • 11.2.2 Novartis AG Business Overview
  • 11.2.3 Novartis AG Neuropathic Pain Therapeutics Introduction
  • 11.2.4 Novartis AG Revenue in Neuropathic Pain Therapeutics Business (2015-2020)
  • 11.2.5 Novartis AG Recent Development
• 11.3 AstraZeneca
  • 11.3.1 AstraZeneca Company Details
  • 11.3.2 AstraZeneca Business Overview
  • 11.3.3 AstraZeneca Neuropathic Pain Therapeutics Introduction
  • 11.3.4 AstraZeneca Revenue in Neuropathic Pain Therapeutics Business (2015-2020)
  • 11.3.5 AstraZeneca Recent Development
• 11.4 GlaxoSmithKline
  • 11.4.1 GlaxoSmithKline Company Details
  • 11.4.2 GlaxoSmithKline Business Overview
  • 11.4.3 GlaxoSmithKline Neuropathic Pain Therapeutics Introduction
  • 11.4.4 GlaxoSmithKline Revenue in Neuropathic Pain Therapeutics Business (2015-2020)
  • 11.4.5 GlaxoSmithKline Recent Development
• 11.5 Eli Lilly and Company
  • 11.5.1 Eli Lilly and Company Company Details
  • 11.5.2 Eli Lilly and Company Business Overview
  • 11.5.3 Eli Lilly and Company Neuropathic Pain Therapeutics Introduction
  • 11.5.4 Eli Lilly and Company Revenue in Neuropathic Pain Therapeutics Business (2015-2020)
  • 11.5.5 Eli Lilly and Company Recent Development
• 11.6 Mallinckrodt Pharmaceuticals
  • 11.6.1 Mallinckrodt Pharmaceuticals Company Details
  • 11.6.2 Mallinckrodt Pharmaceuticals Business Overview
  • 11.6.3 Mallinckrodt Pharmaceuticals Neuropathic Pain Therapeutics Introduction
  • 11.6.4 Mallinckrodt Pharmaceuticals Revenue in Neuropathic Pain Therapeutics Business (2015-2020)
  • 11.6.5 Mallinckrodt Pharmaceuticals Recent Development
• 11.7 Johnson & Johnson
  • 11.7.1 Johnson & Johnson Company Details
  • 11.7.2 Johnson & Johnson Business Overview
  • 11.7.3 Johnson & Johnson Neuropathic Pain Therapeutics Introduction
  • 11.7.4 Johnson & Johnson Revenue in Neuropathic Pain Therapeutics Business (2015-2020)
  • 11.7.5 Johnson & Johnson Recent Development
• 11.8 Abbott
  • 11.8.1 Abbott Company Details
  • 11.8.2 Abbott Business Overview
  • 11.8.3 Abbott Neuropathic Pain Therapeutics Introduction
  • 11.8.4 Abbott Revenue in Neuropathic Pain Therapeutics Business (2015-2020)
  • 11.8.5 Abbott Recent Development
• 11.9 Endo Pharmaceuticals, Inc.
  • 11.9.1 Endo Pharmaceuticals, Inc. Company Details
  • 11.9.2 Endo Pharmaceuticals, Inc. Business Overview
  • 11.9.3 Endo Pharmaceuticals, Inc. Neuropathic Pain Therapeutics Introduction
  • 11.9.4 Endo Pharmaceuticals, Inc. Revenue in Neuropathic Pain Therapeutics Business (2015-2020)
  • 11.9.5 Endo Pharmaceuticals, Inc. Recent Development
• 11.10 Teva Pharmaceutical Industries Limited
  • 11.10.1 Teva Pharmaceutical Industries Limited Company Details
  • 11.10.2 Teva Pharmaceutical Industries Limited Business Overview
  • 11.10.3 Teva Pharmaceutical Industries Limited Neuropathic Pain Therapeutics Introduction
  • 11.10.4 Teva Pharmaceutical Industries Limited Revenue in Neuropathic Pain Therapeutics Business (2015-2020)
  • 11.10.5 Teva Pharmaceutical Industries Limited Recent Development
• 11.11 Merck & Co
  • 10.11.1 Merck & Co Company Details
  • 10.11.2 Merck & Co Business Overview
  • 10.11.3 Merck & Co Neuropathic Pain Therapeutics Introduction
  • 10.11.4 Merck & Co Revenue in Neuropathic Pain Therapeutics Business (2015-2020)
  • 10.11.5 Merck & Co Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer